Baird Financial Group
ONC

Baird Financial Group’s BeOne Medicines Ltd ONC Stock Holding History

Baird Financial Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105M Buy
368,978
+19,327
+6% +$5.7M 0.14% 103
2026
Q1 		$104M Buy
349,651
+45,312
+15% +$14.7M 0.16% 96
2025
Q4 		$92.5M Sell
304,339
-38,583
-11% -$12.6M 0.14% 107
2025
Q3 		$117M Buy
342,922
+480
+0.1% +$146K 0.19% 84
2025
Q2 		$82.9M Buy
342,442
+68,046
+25% +$16.7M 0.15% 117
2025
Q1 		$74.7M Sell
274,396
-21,166
-7% -$4.95M 0.14% 124
2024
Q4 		$54.6M Buy
295,562
+8,448
+3% +$1.73M 0.1% 177
2024
Q3 		$64.5M Buy
287,114
+25,004
+10% +$4.5M 0.13% 163
2024
Q2 		$37.4M Buy
262,110
+11,243
+4% +$1.73M 0.08% 235
2024
Q1 		$39.2M Buy
250,867
+85,934
+52% +$13.8M 0.08% 227
2023
Q4 		$29.7M Buy
164,933
+34,481
+26% +$6.24M 0.07% 251
2023
Q3 		$23.5M Buy
130,452
+15,264
+13% +$3.02M 0.06% 256
2023
Q2 		$20.5M Buy
115,188
+8,982
+8% +$2.07M 0.05% 294
2023
Q1 		$22.9M Buy
106,206
+3,006
+3% +$721K 0.06% 281
2022
Q4 		$22.7M Sell
103,200
-376
-0.4% -$69K 0.06% 281
2022
Q3 		$14M Buy
103,576
+5,804
+6% +$997K 0.04% 348
2022
Q2 		$15.8M Buy
97,772
+4,170
+4% +$651K 0.04% 345
2022
Q1 		$17.7M Buy
93,602
+8,967
+11% +$1.91M 0.04% 333
2021
Q4 		$22.9M Buy
84,635
+643
+0.8% +$217K 0.05% 295
2021
Q3 		$30.5M Buy
83,992
+4,123
+5% +$1.35M 0.08% 238
2021
Q2 		$27.4M Buy
79,869
+6,465
+9% +$2.14M 0.07% 252
2021
Q1 		$25.6M Sell
73,404
-8,589
-10% -$2.84M 0.07% 249
2020
Q4 		$21.2M Buy
81,993
+2,040
+3% +$562K 0.06% 274
2020
Q3 		$22.9M Buy
79,953
+2,336
+3% +$549K 0.08% 243
2020
Q2 		$15K Buy
77,617
+2,982
+4% +$485K ﹤0.01% 1503
2020
Q1 		$9.19M Buy
+74,635
New +$11.7M 0.04% 338

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Baird Financial Group's ONC Position: Q2 2026 in Review

Baird Financial Group increased its BeOne Medicines Ltd (ONC) stake by 5.5% in Q2 2026, buying an estimated $5.7M and bringing the position to 368,978 shares worth $105M. The position accounts for 0.14% of the portfolio, ranked #103.

Baird Financial Group first reported a position in ONC in Q1 2020 and has held it in 26 quarters since. The position peaked at $117M in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Baird Financial Group held 368,978 shares of BeOne Medicines Ltd worth $105M as of Q2 2026.
  • Baird Financial Group bought 19,327 BeOne Medicines Ltd shares in Q2 2026, an estimated $5.7M.
  • BeOne Medicines Ltd made up 0.14% of Baird Financial Group's portfolio in Q2 2026, its #103 holding.
  • Baird Financial Group first reported a position in BeOne Medicines Ltd in Q1 2020 and has held it in 26 quarters since.
  • Baird Financial Group's BeOne Medicines Ltd position peaked at $117M in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.